1. Home
  2. FPI vs EYPT Comparison

FPI vs EYPT Comparison

Compare FPI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.82

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$18.43

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
EYPT
Founded
2013
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
1.5B
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
FPI
EYPT
Price
$9.82
$18.43
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$29.60
AVG Volume (30 Days)
581.6K
1.3M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
2.45%
N/A
EPS Growth
296.76
N/A
EPS
1.27
N/A
Revenue
$52,990,000.00
$42,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$3.91
52 Week High
$12.87
$19.11

Technical Indicators

Market Signals
Indicator
FPI
EYPT
Relative Strength Index (RSI) 43.27 67.75
Support Level $9.65 $16.52
Resistance Level $10.53 $19.00
Average True Range (ATR) 0.15 1.17
MACD -0.00 0.12
Stochastic Oscillator 11.88 84.71

Price Performance

Historical Comparison
FPI
EYPT

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: